Filgotinib in ulcerative colitis: early real-world experience in Southampton

被引:0
|
作者
Taylor, Deborah [1 ]
Young, David [1 ,2 ]
Rahmany, Sohail [1 ]
Bettey, Marion [1 ]
Oppong, Philip [1 ]
Harris, Richard [1 ]
Smith, Trevor [1 ]
Felwick, Richard [1 ]
Gwiggner, Markus [1 ]
Cummings, Fraser [1 ,2 ]
机构
[1] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
[2] Univ Southampton, Southampton, Hants, England
关键词
D O I
10.1136/gutjnl-2023-BSG.186
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P114
引用
收藏
页码:A113 / A113
页数:1
相关论文
共 50 条
  • [41] Real-world experience of using Tofacitinib in Ulcerative Colitis in biologic naive and biologic exposed patients
    Cheesbrough, J.
    Quraishi, M. N.
    Sharma, N.
    Nassar, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I443 - I444
  • [42] REAL-WORLD EXPERIENCE AND PERSPECTIVES ON THE TREATMENT OF ULCERATIVE COLITIS: RESULTS FROM A HEALTHCARE PROVIDER SURVEY
    Hunter, Theresa
    Sweeney, Carolyn
    Wolin, Daniel
    Mcsorley, David
    Wang, Jinyi
    Koushik, Amit Kumar
    Moses, Richard
    Dubinsky, Marla
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S84 - S85
  • [43] Upadacitinib for rescue therapy in patients with acute severe ulcerative colitis: An Australian real-world experience
    Tan, W. L.
    Gilmore, R.
    Huang, A.
    Fernandes, R.
    An, Y-K
    Begun, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 182 - 182
  • [44] Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
    D'Amico, Ferdinando
    Parigi, Tommaso Lorenzo
    Fiorino, Gionata
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [45] REAL-WORLD EXPERIENCE OF USING TOFACITINIB IN ULCERATIVE COLITIS IN BIOLOGIC NAIVE AND BIOLOGIC EXPOSED PATIENTS
    Cheesbrough, Jonathan
    Sharma, Naveen
    Nassar, Islam
    Quraishi, Nabil
    GUT, 2022, 71 : A42 - A42
  • [46] Real-world use and effectiveness of golimumab for ulcerative colitis in Canada
    Bressler, B.
    Williamson, M.
    Camacho, F.
    Sattin, B.
    Steinhart, A. H.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S396 - S396
  • [47] Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)
    Pulusu, S. S. R.
    Srinivasan, A.
    Krishnaprasad, K.
    Cheng, D.
    Mogilevski, T.
    Flanagan, E.
    Keung, C.
    Wu, C.
    Prosser, R.
    Sawyer, E.
    Rizvi, Q. -U. -A.
    Su, H.
    Leung, W. -K.
    Edmundson, A.
    Cooke, S.
    Mahy, G.
    Thin, L.
    Radford-Smith, G.
    Sparrow, M.
    Andrews, J. M.
    Connor, S.
    Bampton, P.
    Ghaly, S.
    Van Langenberg, D.
    Bell, S.
    De Cruz, P.
    Begun, J.
    Ng, S.
    Travis, S.
    Lawrance, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S395 - S396
  • [48] Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
    Deepak, Parakkal
    Alayo, Quazim A.
    Khatiwada, Aava
    Lin, Bixuan
    Fenster, Marc
    Dimopoulos, Christina
    Bader, Geoffrey
    Weisshof, Roni
    Jacobs, Michael
    Gutierrez, Alexandra
    Ciorba, Matthew A.
    Christophi, George P.
    Patel, Anish
    Hirten, Robert P.
    Colombel, Jean-Frederic
    Rubin, David T.
    Ha, Christina
    Beniwal-Patel, Poonam
    Ungaro, Ryan C.
    Syal, Gaurav
    Pekow, Joel
    Cohen, Benjamin L.
    Yarur, Andres
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (08) : 1592 - +
  • [49] SELECTION: filgotinib for ulcerative colitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (12): : 1036 - 1037
  • [50] Real-world effectiveness and safety of filgotinib with and without concomitant therapies in patients with Ulcerative Colitis: an interim analysis of the prospective, observational GALOCEAN study
    Hoivik, M.
    Vermeire, S.
    Reinisch, W.
    Seenan, J. P.
    Lowenberg, M.
    Schreiber, S.
    Armuzzi, A.
    Ricart, E.
    Doherty, G.
    Saldana, R.
    Sawyer, W.
    Rudolph, C.
    Jus, A.
    Joseph, C. Gilletta de Saint
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1884 - i1885